Hot Stocks

The stock market changes from minute to minute, and what’s hot today may not be hot tomorrow. Our expert analysts spot hot stocks that are heating up before the crowd swoops in to bid prices higher, and our journalists sift through the noise to shine a light on trending investments -- in spaces ranging from quantum computing to marijuana stocks -- to determine whether they’re actually worth your time.

Pfizer Stock Pops on Vaccine Timeline News, Trial Expansion

Pfizer stock and partner BioNTech are rallying Monday morning on news the two companies could vaccinate Americans before the end of 2020.

Plug Power Is in the Driver’s Seat as Hydrogen Use Grows

Mega deals for Plug Power from companies like Walmart and Home Depot are set to lift PLUG stock further.

The Reward of Buying Carnival Shares Isn’t Worth the Risk

Carnival is taking its first steps toward normalcy, and CCL stock may have calmer waters ahead. Still, remaining risks may curtail growth.

CureVac Stock Is Just Another Part of a Bigger Story

With its Covid-19 vaccine candidate, CureVac stock soared after its IPO in August. But as Operation Warp Speed wraps up, investors may wonder if there's anything else.

Sorrento Therapeutics Is a Scary, Risky Potential Buy

Sorrento Therapeutics has lost 44% since firing its chief financial officer on Aug. 19. Is SRNE stock a buy given its drop in recent days?

Don’t Bother With United Airlines When Low-Cost Carriers Are Better Buys

With a vaccine still in progress, and low-cost airlines better recovery plays, there's little reason to dive into UAL stock right now.

It’s Not Over Yet for Novavax Stock, but Wait for Another Pullback

While factors could change the game, you can't say it's over for NVAX stock. Still, wait for lower prices before diving into high-risk, high-return Novavax.

Here’s Why IBIO’s Choice of IBIO-201 in the Vaccine Race is a Good Thing

Ibio recently announced IBIO-201 as its coronavirus vaccine candidate. Despite a long road ahead, it’s good news for IBIO stock.   

Rio Tinto CEO Resigns Amid Furor Over Destruction of Ancient Juukan Gorge Caves

Rio Tinto (RIO) has announced the resignation of its CEO following outgrade after the destruction of Juukan caves earlier this year.

After Analyst Upgrade, Roku Stock Aims At $215 Price Target

Roku’s success as a streaming platform that makes more from ads and licensing than hardware has won an analyst upgrade for Roku stock.

Next Citibank CEO: 10 Things to Know About Jane Fraser

Citibank, a subsidiary of Citigroup (C), has announced that Jane Fraser is taking over as its next CEO starting in February 2021.

It’s Far Too Soon to Expect a Comeback for Southwest Airlines

A Morgan Stanley analyst says Southwest Airlines will rally 30% in the next year, but a lot has to go right for LUV stock to see those gains.

Post-Bankruptcy, Whiting Petroleum an Intriguing Choice for Oil Bulls

Bankruptcy improved Whiting's balance sheet. As a result, the "new" WLL stock has a chance to provide solid returns – if crude cooperates.

Hologic News: HOLX Stock Heads 4% Higher on Bright Outlook

Hologic (HOLX) is in the news Friday after announcing updated guidance for its fiscal Q4 of 2020 that sent HOLX stock soaring higher.

It May Take Some Time but Delta Air Lines Will Turn Around

It may take some time but Delta Air Lines will turn around. DAL stock could easily double over the next two and a half years or at least 32% annually as its recovery takes hold.

Kodak News: Why KODK Stock Is Surging Again Today

KODK stock is rising again on Friday after investment management firm Southeastern Asset Management changed its position in Eastman Kodak.

Avinger News: AVGR Stock Down 8% Following FDA Approval

Avinger (AVGR) news for Friday concerning approval from the FDA for one of its medical devices has AVGR stock on the move.

Kroger Earnings: KR Stock Ticks 1% Lower Despite Q2 Beat

Kroger (KR) earnings for the retail company's second quarter of the year have KR stock down on Friday despite beating estimates.

Why the Coronavirus May Have Disrupted Ocugen

In analyzing the science behind OCGN stock, the innovation is quite profound. However, it’s this very platform that is under serious scrutiny thanks to the coronavirus.